Drug-resistant tuberculosis in children in Thailand

K Lapphra1, C Sutthipong, S Foongladda

  • 1Department of Paediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Insights

Drug-resistant tuberculosis (DR-TB) is a significant concern in Thai children, with a 34% resistance rate found. Prior treatment and chest X-ray findings like atelectasis are key risk factors for DR-TB in pediatric patients.

Area of Science:

  • Pediatric infectious diseases
  • Mycobacterial infections
  • Public health epidemiology

Background:

  • Limited data exists on drug-resistant tuberculosis (DR-TB) in children within Thailand.
  • Understanding the prevalence and characteristics of DR-TB in pediatric populations is crucial for effective control strategies.

Purpose of the Study:

  • To determine the incidence, clinical presentation, and risk factors associated with drug-resistant tuberculosis (DR-TB) in children.
  • To provide essential data for improving the management of DR-TB in pediatric cases in Thailand.

Main Methods:

  • An observational prospective study was conducted involving children diagnosed with tuberculosis (TB) at a tertiary care center in Bangkok.
  • Diagnostic methods included culture and polymerase chain reaction for TB detection, followed by drug susceptibility testing (DST) for positive specimens.

Main Results:

  • Out of 230 children with TB, 34% of tested specimens showed some form of drug resistance, including multidrug-resistant TB (MDR-TB).
  • Factors significantly associated with DR-TB included a history of prior TB treatment and radiographic evidence of atelectasis or lobar consolidation.
  • While DR-TB cases required longer treatment durations, cure rates, treatment completion, and mortality did not differ significantly compared to drug-susceptible TB.

Conclusions:

  • The high prevalence of DR-TB highlights the necessity of routine drug susceptibility testing (DST) in children diagnosed with TB.
  • Information on prior treatment history and drug susceptibility patterns in adult source cases can effectively guide initial treatment decisions for children.
Abstract

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...